ERBB2 and breast cancer: (All four clinical treatment groups of breast cancer we have analyzed (HR+/HER2- tumors, HR-/HER2+ tumors, HR+/HER2+ tumors, and TN breast tumors) expressed similar densities of tumor peripheral FSHR+ blood vessels).